KR100893328B1 - 정신신경질환 약품 - Google Patents
정신신경질환 약품 Download PDFInfo
- Publication number
- KR100893328B1 KR100893328B1 KR1020037011641A KR20037011641A KR100893328B1 KR 100893328 B1 KR100893328 B1 KR 100893328B1 KR 1020037011641 A KR1020037011641 A KR 1020037011641A KR 20037011641 A KR20037011641 A KR 20037011641A KR 100893328 B1 KR100893328 B1 KR 100893328B1
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- delete delete
- hydrogen
- opioid
- methyl
- Prior art date
Links
- 0 *c1ccc(CC(N2C(CN3CCCC3)C*CC2)=O)cc1* Chemical compound *c1ccc(CC(N2C(CN3CCCC3)C*CC2)=O)cc1* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Paper (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
Description
(단, 이들 식 중, Q는 -NH-, -O- 또는 -S-를 나타내고, T는 -CH2-, -NH-, -S- 또는 -O-를 나타내고, l는 0∼5의 정수, m 및 n은 각각 독립적으로 0이상인 정수로서 양자의 합이 5이하인 정수를 나타낸다)
을 갖는 유기기(단, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알카노일옥시, 히드록시, 불소, 염소, 브롬, 요오드, 아미노, 니트로, 시아노, 이소티오시아네이토, 트리플루오로메틸, 트리플루오로메톡시, 메틸렌디옥시로 이루어지는 군으로부터 선택된 1종 이상의 치환기에 의해 치환되어 있어도 좋다)를 나타내고 , R6은 수소, R7은 수소, 히드록시, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알카노일옥시, 또는 R6과 R7은 하나로 되어 -O-, -CH2-, -S-를 나타내고, R8은 수소, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알카노일을 나타내고, 또한, 일반식(I)는 (+)체, (-)체, (±)체를 포함한다.]
Claims (21)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001100797 | 2001-03-30 | ||
JPJP-P-2001-00100797 | 2001-03-30 | ||
PCT/JP2002/003156 WO2002078744A1 (fr) | 2001-03-30 | 2002-03-29 | Remedes contre la psychonevrose |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030086288A KR20030086288A (ko) | 2003-11-07 |
KR100893328B1 true KR100893328B1 (ko) | 2009-04-14 |
Family
ID=18954209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037011641A KR100893328B1 (ko) | 2001-03-30 | 2002-03-29 | 정신신경질환 약품 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8338442B2 (ko) |
EP (1) | EP1380306B1 (ko) |
JP (1) | JP4453254B2 (ko) |
KR (1) | KR100893328B1 (ko) |
CN (1) | CN100398154C (ko) |
AT (1) | ATE424205T1 (ko) |
AU (1) | AU2002241326B2 (ko) |
CA (1) | CA2442423C (ko) |
DE (1) | DE60231388D1 (ko) |
ES (1) | ES2319265T3 (ko) |
PT (1) | PT1380306E (ko) |
WO (1) | WO2002078744A1 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
CA2685126C (en) | 2007-04-24 | 2015-04-14 | Toray Industries, Inc. | Therapeutic or prophylactic agent for dyskinesia |
AU2008268202B2 (en) | 2007-06-22 | 2012-12-20 | Toray Industries, Inc. | Remedy or preventive for integration dysfunction syndrome |
BRPI0817804A8 (pt) | 2007-10-05 | 2017-04-18 | Toray Industries | Agente terapêutico para melhorar as propriedades da pele compreendendo um derivado de morfinano ou qualquer um de seus sais de adição de ácido farmacologicamente permissíveis como um ingrediente ativo |
AU2011211223B2 (en) * | 2010-01-29 | 2014-10-23 | Toray Industries, Inc. | Therapeutic or prophylactic agent for biliary diseases |
EP2630150B1 (en) * | 2010-10-19 | 2017-04-12 | Memorial Sloan-Kettering Cancer Center | 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain |
MX2013008749A (es) | 2011-01-31 | 2013-10-17 | Toray Industries | Agente terapeutico o profilactico para caquexia. |
EP4212532A3 (en) | 2015-04-30 | 2023-09-27 | Memorial Sloan Kettering Cancer Center | Mitragynine analogs and uses thereof |
EP3761982A4 (en) | 2018-03-08 | 2021-12-15 | Victoria Link Ltd | TREATMENT OF DEMYELINIZATION DISEASES |
IL309232A (en) | 2021-06-14 | 2024-02-01 | Scorpion Therapeutics Inc | History of urea which can be used to treat cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048484A2 (en) * | 1998-03-27 | 1999-09-30 | Pharmacia & Upjohn Company | Use of cabergoline in the treatment of restless legs syndrome |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA842753B (en) * | 1983-05-18 | 1984-11-28 | Upjohn Co | 2-dihydropyrrolyl-cycloalkyl-amide analgesics |
EP0232612B1 (en) | 1985-12-23 | 1990-04-04 | Dr. Lo. Zambeletti S.p.A. | Azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
ES2039242T3 (es) | 1986-09-02 | 1993-09-16 | Dr. Lo. Zambeletti S.P.A. | Un procedimiento para la preparacion de nuevos derivados de piperidina. |
AU603850B2 (en) * | 1986-12-22 | 1990-11-29 | Dr. Lo Zambeletti S.P.A. | Novel piperidine derivatives |
GB9105152D0 (en) | 1991-03-12 | 1991-04-24 | Glaxo Group Ltd | Chemical compounds |
ES2121988T3 (es) * | 1992-01-23 | 1998-12-16 | Toray Industries | Derivado de morfinano y uso medicinal. |
JPH06122677A (ja) * | 1992-08-28 | 1994-05-06 | Sankyo Co Ltd | 光学活性なカルボン酸アミド誘導体 |
EP1327444B1 (en) | 1996-11-25 | 2005-03-23 | Toray Industries, Inc. | Antipruritic agent |
EP0974363B1 (en) * | 1997-09-02 | 2005-06-22 | Toray Industries, Inc. | Remedies for drug addiction |
SE9803760D0 (sv) * | 1998-11-04 | 1998-11-04 | Jan Hedner | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
DE19938823A1 (de) * | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
-
2002
- 2002-03-29 PT PT02707244T patent/PT1380306E/pt unknown
- 2002-03-29 ES ES02707244T patent/ES2319265T3/es not_active Expired - Lifetime
- 2002-03-29 AT AT02707244T patent/ATE424205T1/de active
- 2002-03-29 AU AU2002241326A patent/AU2002241326B2/en not_active Expired
- 2002-03-29 CA CA002442423A patent/CA2442423C/en not_active Expired - Lifetime
- 2002-03-29 US US10/473,541 patent/US8338442B2/en active Active
- 2002-03-29 KR KR1020037011641A patent/KR100893328B1/ko active IP Right Grant
- 2002-03-29 EP EP02707244A patent/EP1380306B1/en not_active Expired - Lifetime
- 2002-03-29 JP JP2002586270A patent/JP4453254B2/ja not_active Expired - Fee Related
- 2002-03-29 WO PCT/JP2002/003156 patent/WO2002078744A1/ja active Application Filing
- 2002-03-29 CN CNB02807257XA patent/CN100398154C/zh not_active Expired - Lifetime
- 2002-03-29 DE DE60231388T patent/DE60231388D1/de not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048484A2 (en) * | 1998-03-27 | 1999-09-30 | Pharmacia & Upjohn Company | Use of cabergoline in the treatment of restless legs syndrome |
Non-Patent Citations (2)
Title |
---|
GIULIANI, S. etal., Role of opoid receptors in modulating cholinergic twitches in the circular muscle of quineapig coln. Br.j.Phamacol., 1986, 119,pp.985-989 |
SAITO, T. et al.,Erinacine E as a Kappa Opioid Receptor Agonist and Its New Analogs from a Basidiomycete, Hericiumramosum.J.Antibiot., 1998,51(11), pp.983-990 |
Also Published As
Publication number | Publication date |
---|---|
CA2442423A1 (en) | 2002-10-10 |
PT1380306E (pt) | 2009-05-25 |
CA2442423C (en) | 2009-11-03 |
ATE424205T1 (de) | 2009-03-15 |
KR20030086288A (ko) | 2003-11-07 |
US8338442B2 (en) | 2012-12-25 |
WO2002078744A1 (fr) | 2002-10-10 |
JP4453254B2 (ja) | 2010-04-21 |
CN100398154C (zh) | 2008-07-02 |
JPWO2002078744A1 (ja) | 2004-07-22 |
DE60231388D1 (de) | 2009-04-16 |
EP1380306A4 (en) | 2005-06-08 |
CN1537016A (zh) | 2004-10-13 |
EP1380306A1 (en) | 2004-01-14 |
ES2319265T3 (es) | 2009-05-06 |
EP1380306B1 (en) | 2009-03-04 |
US20040116456A1 (en) | 2004-06-17 |
AU2002241326B2 (en) | 2007-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0897726B1 (en) | Antipruritic agent | |
AU756120B2 (en) | Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds | |
KR100893328B1 (ko) | 정신신경질환 약품 | |
JP2003509371A (ja) | 5−ヒドロキシトリプタミン・レセプタ/α2アドレナリン作用性レセプタ拮抗薬組成物の投与による運動障害の処置 | |
KR101324539B1 (ko) | 다발성 경화증에 따른 가려움의 치료에 사용하는 제품 | |
KR20120139713A (ko) | 담도 질환의 치료 또는 예방제 | |
CA2383146C (en) | Therapeutic agent for neuropathic pain and neuropathic pain animal model | |
JP2001503394A (ja) | 神経障害または神経精神障害の処置法 | |
KR101477043B1 (ko) | 디스키네시아의 치료 또는 예방제 | |
JP2021511338A (ja) | 睡眠障害の治療及び予防 | |
US6440987B1 (en) | Antipruritic | |
KR20030024877A (ko) | 중독성 질환의 치료용 화합물 | |
JPH1192376A (ja) | ニコチン依存症治療剤 | |
EP1010425A9 (en) | Remedies for irritable bowel syndrome | |
JP3531170B6 (ja) | 止痒剤 | |
EP4255428A1 (en) | Treatment of pain and neurological conditions | |
WO2004078177A1 (ja) | 薬物・物質依存治療薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130321 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140319 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160318 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170302 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180316 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190319 Year of fee payment: 11 |